Genomics4S

As genomic technologies move from treating disease to selecting future individuals, definitions of disease cease to function exclusively as medical categories and become social decisions about which traits and what kinds of people should exist.

While the recent adoption of a flexible clinical translation model in Hainan Province promises to accelerate biomedical innovation in China, it has also intensified concerns about patient safety, transparency, and misinformation. The success of this new approach is largely dependent on strengthening post-market oversight, access to clinical data, and strategic alignment with international bioethical guidelines.

The ability to reduce the burden of genetic disease is one of the most compelling promises of genomic medicine. But the path forward for embryo selection and gene editing is not purely technical; it demands rigorous evaluation of scientific evidence, sustained ethical reflection, and broad public consensus.

The global AI in clinical trials market, valued at US$1.20 billion in 2023, is projected to grow at a 12.4% annually, reaching US$2.74 billion by 2030. As AI reshapes how patients are identified, matched, and enrolled in clinical research, regulatory frameworks must evolve to address the structural diversity, data flows, and ethical risks embedded in these emerging platforms.

AI systems require public data and cooperation to function responsibly, yet people won’t share their data unless they already trust the systems collecting and utilizing it. Solving this paradox must be a policy priority for developers and the Canadian government.

By focusing on fairness, accountability, and transparency, we can guarantee that AI-driven innovations in clinical trials improve—rather...

In search for a perfect baby, early adopters do not shy away from using unproven genetic screening technologies. In a recent article in...

With the advent of AI in healthcare, expertise and experiences accrued in ethics oversight of other controversial fields of biomedical...

Emotion recognition AI may not compromise the integrity of our bodies directly, but it can undermine our personal autonomy and free will.

Whole genome sequencing can provide an incredible amount of useful genetic and personal health information, however, there are a number...

Genomics4S Research Director co-authors a new publication that highlights the lack of critical discourse on the issue of human gene...

Media representations of regenerative medicine across countries and continents have consistently conveyed an overtly optimistic view on the

Human brain organoid research offers immense promise for biomedicine but many uncertainties surround the ethical status of organoids and...

The coronavirus pandemic has revealed critical flaws in Canada's long-term care system, leaving seniors unguarded in the face of a global...

The lack of robust science behind the current social distancing rules contributes to uncertainty and raises legitimate questions about...

More than any other recent global health crises, the COVID-19 pandemic has highlighted the need to embrace a new sense of global...

A new book by Genomics4S Research Fellow Dr. Samuel Ujewe and colleagues scrutinizes the socio-cultural dimensions of emerging infectious...

As provincial policies in Canada remain ineffective in addressing the declining vaccination rates, there is a strong public support for...

The curious case of Emile Ratelband opens up a heated bioethical debate on whether people's chronological age is less important than...

After a mumps outbreak at Temple, the University administration decided to enforce strict immunization rules, similar to measures at...